Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.64 |
| ▸ | S100A4 | P26447 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 3/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | USP8 | P40818 | 1/20 | 0.42 |
| ▸ | USP7 | Q93009 | 1/20 | 0.42 |
| ▸ | USP47 | Q96K76 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19152440 | 0.87 | S100A4 (0.53) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL31106330 | 0.87 | S100A4 (0.53) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL22289446 | 0.83 | DNMT1 (0.54) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL31195807 | 0.83 | DNMT1 (0.54) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL16144670 | 0.82 | DNMT1 (0.67) | DNMT1MEN1ALDH1A1KMT2AMAPT | |
| SCHEMBL2175783 | 0.82 | DNMT1 (0.92) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL30375875 | 0.82 | DNMT1 (0.92) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL29440308 | 0.82 | DNMT1 (0.92) | DNMT1S100A4MEN1ALDH1A1KMT2A | |
| SCHEMBL19230419 | 0.82 | DNMT1 (0.83) | DNMT1MEN1ALDH1A1KMT2AMAPT | |
| SCHEMBL7818661 | 0.81 | DNMT1 (0.56) | DNMT1S100A4MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10283716-B2 | Compound for organic electric element, organic electric element using the same, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2019-05-07 | — | — | US | disclosed |
| US-20180026187-A1 | NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20180026187-A1 | NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| WO-2017123008-A1 | ORGANIC LIGHT-EMITTING DEVICE, ORGANIC LIGHT-EMITTING DISPLAY DEVICE, AND COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE | 덕산네오룩스 주식회사 | 2017-07-20 | — | — | WO | disclosed |
| WO-2017123008-A1 | ORGANIC LIGHT-EMITTING DEVICE, ORGANIC LIGHT-EMITTING DISPLAY DEVICE, AND COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE | 덕산네오룩스 주식회사 | 2017-07-20 | — | — | WO | disclosed |
| WO-2013015340-A1 | 2-ARYL HALIDE-1-NAPHTHALDEHYDE COMPOUND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING TRIARYLAMINE COMPOUND FROM SAID COMPOUND | 東ソー株式会社 (JP) | 2013-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180026187-A1 | NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME | EBPL, OR51E2, EML4 | DNMT1 340/4885S100A4 3206/4885MEN1 1483/4885 |
| US-10283716-B2 | Compound for organic electric element, organic electric element using the same, and electronic device comprising same | EBPL, OR51E2, EML4 | DNMT1 167/4885S100A4 3119/4885MEN1 1376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.